CAMX:STO
Camurus AB
740,00 SEK
arrow_downward
-0,67%(-5,00) 1D
16 նոյ, 17:29:39 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CAMX...
Open
745,00 SEK
High
750,00 SEK
Low
740,00 SEK
Mkt. cap
45,12 մլրդ
Avg. vol.
109,05 հզր
Volume
97,74 հզր
52-wk high
750,00 SEK
52-wk low
430,80 SEK
Shares outstanding
60,56 մլն
No. of employees
323
Open
745,00 SEK
High
750,00 SEK
Low
740,00 SEK
Mkt. cap
45,12 մլրդ
Avg. vol.
109,05 հզր
Volume
97,74 հզր
52-wk high
750,00 SEK
52-wk low
430,80 SEK
Shares outstanding
60,56 մլն
No. of employees
323
News stories
From web sources and news partners
Bloomberg.com
·
1 ժամ առաջ
Wells Fargo Sees S&P 500 at 8,200 By End of 2027 as Profits Slow
RealMoney Pro
·
1 ժամ առաջ
AI Stocks Drag the S&P 500 Back Toward the November 5th Lows
Investing.com
·
2 ժամ առաջ
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
Traders Union
·
48 րոպե առաջ
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
Profile
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
About Camurus AB